These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 946973)

  • 1. Safety and efficacy of "Alice" influenza virus vaccine in normal healthy adults.
    Zaky DA; Douglas RG; Betts RF; Roth FK; Rinehart CJ; Hogan PW
    J Infect Dis; 1976 Jun; 133(6):669-75. PubMed ID: 946973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live, attenuated influenza A/England/42/72 (H3N2) virus vaccine: a field trial.
    Rubin RJ; Noble GR; Corey L; Brown WJ; Brandling-Bennett D; Kaye HS; Coleman MT; Gregg MB; Dowdle WR
    J Infect Dis; 1976 Jun; 133(6):613-20. PubMed ID: 778302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of an inhibitor-resistant live attenuated influenza vaccine in normal and asthmatic adults.
    Warshauer DM; Minor TE; Inhorn SL; Reed CE; Dick EC
    Dev Biol Stand; 1976; 33():184-90. PubMed ID: 782967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New live attenuated influenza A/England/42/72 (H3N2) vaccine (Alice): reactogenicity,, immunogenicity, and protection efficacy.
    Rytel MW; Jackson LJ; Ferstenfeld JE; Rosenkranz MA
    J Infect Dis; 1975 Dec; 132(6):652-9. PubMed ID: 1202110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuated influenza A vaccine (Alice) in an adult population: vaccine-related illness, serum and nasal antibody production, and intrafamily transmission.
    Minor TE; Dick EC; Dick CR; Inhorn SL
    J Clin Microbiol; 1975 Nov; 2(5):403-9. PubMed ID: 1104655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines.
    Potter CW; Jennings R; Nicholson K; Tyrrell DA; Dickinson KG
    J Hyg (Lond); 1977 Dec; 79(3):321-32. PubMed ID: 270523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials with Alice strain, live, attenuated, serum inhibitor-resistant intranasal influenza A vaccine.
    Spencer MJ; Cherry JD; Powell KR; Sumaya CV; Garakian AJ
    J Infect Dis; 1975 Oct; 132(4):415-20. PubMed ID: 1102614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HL-A antigens and antibody response after influenza A vaccination. Decreased response associated with HL-A type W16.
    Spencer MJ; Cherry JD; Terasaki PI
    N Engl J Med; 1976 Jan; 294(1):13-6. PubMed ID: 1105178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of live attenuated influenza A/Scotland/74 (H3N2) virus vaccine against challenge with influenza A/Victoria/3/75 (H3N2) virus.
    Betts RF; Douglas RG; Roth FK; little JW
    J Infect Dis; 1977 Dec; 136(6):746-53. PubMed ID: 925382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and serologic effects of Alice strain live attenuated influenza A (H3N2) virus vaccine in an adult population.
    Miller LW; Togo Y; Hornick RB
    Med Microbiol Immunol; 1975 Dec; 162(1):15-21. PubMed ID: 1214706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of neuraminidase monospecific (HEqN2) recombinant influenza vaccine in children.
    Beutner KR; Rizzone C; DeMello S; Ogra PL
    Dev Biol Stand; 1976; 33():162-70. PubMed ID: 782964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-response relationship after immunization of volunteers with a new, surface-antigen-adsorbed influenza virus vaccine.
    Potter CW; Jennings R; Phair JP; Clarke A; Stuart-Harris CH
    J Infect Dis; 1977 Mar; 135(3):423-31. PubMed ID: 850080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative trial of influenza vaccines. I. Immunogenicity of whole virus and split product vaccines in man.
    Barry DW; Mayner RE; Staton E; Dunlap RC; Rastogi SC; Hannah JE; Blackburn RJ; Nortman DF; Graze PR
    Am J Epidemiol; 1976 Jul; 104(1):34-46. PubMed ID: 947145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live attenuated influenza virus vaccines in patients with chronic broncho-pulmonary diseases. Clinical and immunological evaluation.
    Prevost JM; Vereerstraeten-Schmerber J; Lamy F; De Koster JP
    Scand J Respir Dis; 1975 May; 56(1):58-69. PubMed ID: 1096297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical trial with Alice/R-75 strain, live attenuated serum inhibitor-resistant intranasal bivalent influenza A/B vaccine.
    Spencer MJ; Cherry JD; Powell KR; Sumaya CV
    Med Microbiol Immunol; 1979 Mar; 167(1):1-9. PubMed ID: 375050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Field trial of live attenuated influenza A/B ("Alice"/R-75) vaccine.
    Rytel MW; Jackson LJ; Niebojewski RA; Haagensen JL; Rosenkranz MA
    Am J Epidemiol; 1977 Jan; 105(1):49-55. PubMed ID: 831465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical control, study of viral shedding and evaluation of circulating and local antibody response after administration of live and attenuated "Alice" strain influenza vaccine].
    Bergamini F; Profeta ML; Ferroni P; Zanetti AR
    Boll Ist Sieroter Milan; 1976 Mar; 55(71):1-12. PubMed ID: 1021151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus.
    Clements ML; O'Donnell S; Levine MM; Chanock RM; Murphy BR
    Infect Immun; 1983 Jun; 40(3):1044-51. PubMed ID: 6852910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of live recombinant influenza vaccine.
    Stealey VM; McCahon D; Freestone DS
    Dev Biol Stand; 1976; 33():191-6. PubMed ID: 955267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of ferrets to infection with a live attenuated influenza virus and to subsequent heterologous challenge.
    Delem A
    Dev Biol Stand; 1976; 33():226-33. PubMed ID: 955269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.